778334007: Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Product manufactured as ocular dose form\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3738227013 Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3738228015 Antazoline and xylometazoline only product in ocular dose form en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Is a	Antazoline + Xylometazoline	true	Inferred relationship	Existential restriction modifier
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Has active ingredient	Xylometazoline	true	Inferred relationship	Existential restriction modifier	1
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Has manufactured dose form	Ocular dose form	true	Inferred relationship	Existential restriction modifier
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Has active ingredient	Antazoline	true	Inferred relationship	Existential restriction modifier	2
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Is a	Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	True	Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3738227013	Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3738228015	Antazoline and xylometazoline only product in ocular dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module